
nChroma Bio
formerly nChromanChroma
nChroma Bio is a biotech company in Boston, United States, founded in 2024. It has raised $470.0M across 4 rounds, most recently a $75.0M Venture Round in December 2024.
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- nchromabio.com
- Total Funding
- $470.0M
- Last Round
- $75.0M Venture RoundDec 2024
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 9 investors for this company. to use credits for reveals, or explore the API.
About
nChroma Bio is a clinical-stage genetic medicines company developing targeted in vivo delivery systems and engineered epigenetic silencers for durable disease treatment. Its lead program, CRMA-1001, is a liver-directed epigenetic therapy in Phase 1/2 trials targeting a functional cure for chronic hepatitis B. The company combines lipid nanoparticle delivery with proprietary epigenetic editing to achieve durable gene silencing without altering the underlying DNA sequence.
Funding History
Dec 2024
3 more funding events
- Series B20233 investors
- Series B20222 investors
- Series A20212 investors
Funding: Series A through Venture Round. Amounts, valuations, and investors where available.
Investors
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- Cloud/Infrastructure ×1
- Engineering & DevOps ×1
- Marketing & SEO ×1
- Other ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nchroma-bio"><img src="https://indexed.vc/api/badge/company/nchroma-bio" alt="nChroma Bio on Indexed.vc" width="260" height="76" /></a>



